Lexum^® Forte (Capsules) Instructions for Use

Marketing Authorization Holder

Koral-Med, CJS (Russia)

Manufactured By

Mega Lifesciences, Ltd. (Thailand)

ATC Code

A05BA (Drugs for the treatment of liver diseases)

Active Substance

Phospholipids (Grouping name)

Dosage Form

Lexum® Forte

Capsules 300 mg: 10, 30, 50 or 100 pcs.

Dosage Form, Packaging, and Composition

10 pcs. – blisters (1) – carton packs.
10 pcs. – blisters (3) – carton packs.
10 pcs. – blisters (10) – carton packs.

Clinical-Pharmacological Group

Hepatoprotective agent

Pharmacotherapeutic Group

Hepatoprotective agent

Pharmacological Action

Hepatoprotective agent, the Phospholipids included in the composition are the main elements in the structure of the cell membrane and mitochondrial membranes.

It participates in lipid and carbohydrate metabolism, improves the functional state of the liver and its detoxification function, promotes the preservation and restoration of the structure of hepatocytes; inhibits the formation of connective tissue in the liver.

Indications

As part of complex therapy: hepatitis (acute and chronic), fatty liver dystrophy of various origins (diabetes mellitus, chronic infections), toxic hepatitis, alcoholic hepatitis, liver cirrhosis, hepatic coma, preeclampsia, radiation sickness, psoriasis, poisoning, drug intoxication, impaired liver function in other somatic diseases.

ICD codes

Dosage Regimen

Orally, 1-2 capsules 2-3 times a day before or during meals.

The capsules should be swallowed whole with a small amount of water. The maximum dose is 6 capsules per day.

For acute hepatitis, treatment is continued for 1-3 months; for chronic liver lesions, regardless of causal factors, treatment is continued for at least 6 months.

The course of treatment can be continued or repeated if necessary.

For psoriasis, it is used as an auxiliary therapy, 2 capsules 3 times a day, the course of treatment is 3 months.

Adverse Reactions

It is usually well tolerated, including with long-term use.

In rare cases, unpleasant sensations in the epigastric region, diarrhea, allergic reactions (skin rash), nausea are possible.

Contraindications

Hypersensitivity, children under 12 years of age.

Use in Pregnancy and Lactation

Use during pregnancy is possible if the potential benefit to the mother outweighs the risk to the fetus and child.

There are no data on use during lactation (breastfeeding). It is recommended to stop breastfeeding during the use of the drug.

Pediatric Use

Contraindicated in children under 12 years of age.

Overdose

Currently, there are no data on cases of overdose.

Storage Conditions

Store the drug in a dry place, protected from light, at a temperature not exceeding 25°C (77°F). Keep out of reach of children.

Shelf Life

Shelf life – 2 years. Do not use the drug after the expiration date.

Dispensing Status

The drug is approved for use as an over-the-counter product.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.